A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic

K. Hansel; A. Zangrilli; L. Bianchi; Ketty Peris; Andrea Chiricozzi; A. Offidani; F. Diotallevi; M. C. Fargnoli; Maria Concetta Fargnoli; M. Esposito; P. Amerio; G. Gualdi; L. Bianchi; L. Stingeni

doi:10.1111/jdv.17003

A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic

K. Hansel
, A. Zangrilli
, L. Bianchi
, Ketty Peris
, Andrea Chiricozzi
, A. Offidani
, F. Diotallevi
, M. C. Fargnoli
, Maria Concetta Fargnoli
, M. Esposito
, P. Amerio
, G. Gualdi
, L. Bianchi
, L. Stingeni

University of Perugia
University of Rome Tor Vergata
Marche Polytechnic University
University of L'Aquila
Gabriele d'Annunzio University

Research output: Contribution to journal › Article

2 Citations (Scopus)

Abstract

na

Original language	English
Pages (from-to)	N/A-N/A
Journal	Journal of the European Academy of Dermatology and Venereology
DOIs	https://doi.org/10.1111/jdv.17003
Publication status	Published - 2020

Keywords

psoriasis
risankizumab

Access to Document

10.1111/jdv.17003

Cite this

Hansel, K., Zangrilli, A., Bianchi, L., Peris, K., Chiricozzi, A., Offidani, A., Diotallevi, F., Fargnoli, M. C., Fargnoli, M. C., Esposito, M., Amerio, P., Gualdi, G., Bianchi, L., & Stingeni, L. (2020). A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology, N/A-N/A. https://doi.org/10.1111/jdv.17003

@article{ebd2de88e3584565b1016b3421724bf9,

title = "A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic",

abstract = "na",

keywords = "psoriasis, risankizumab, psoriasis, risankizumab",

author = "K. Hansel and A. Zangrilli and L. Bianchi and Ketty Peris and Andrea Chiricozzi and A. Offidani and F. Diotallevi and Fargnoli, \{M. C.\} and Fargnoli, \{Maria Concetta\} and M. Esposito and P. Amerio and G. Gualdi and L. Bianchi and L. Stingeni",

year = "2020",

doi = "10.1111/jdv.17003",

language = "English",

pages = "N/A--N/A",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

}

Hansel, K, Zangrilli, A, Bianchi, L, Peris, K, Chiricozzi, A, Offidani, A, Diotallevi, F, Fargnoli, MC, Fargnoli, MC, Esposito, M, Amerio, P, Gualdi, G, Bianchi, L & Stingeni, L 2020, 'A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic', Journal of the European Academy of Dermatology and Venereology, pp. N/A-N/A. https://doi.org/10.1111/jdv.17003

TY - JOUR

T1 - A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic

AU - Hansel, K.

AU - Zangrilli, A.

AU - Bianchi, L.

AU - Peris, Ketty

AU - Chiricozzi, Andrea

AU - Offidani, A.

AU - Diotallevi, F.

AU - Fargnoli, M. C.

AU - Fargnoli, Maria Concetta

AU - Esposito, M.

AU - Amerio, P.

AU - Gualdi, G.

AU - Bianchi, L.

AU - Stingeni, L.

PY - 2020

Y1 - 2020

N2 - na

AB - na

KW - psoriasis

KW - risankizumab

KW - psoriasis

KW - risankizumab

UR - http://hdl.handle.net/10807/168705

U2 - 10.1111/jdv.17003

DO - 10.1111/jdv.17003

M3 - Article

SN - 0926-9959

SP - N/A-N/A

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

ER -

A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this